To evaluating the effect of SGLT2 inhibitor on fine glycemic variability in type 2 diabetes mellitus (T2D) was used a continuous glucose monitoring system (CGMS) Freestyle Libre
Latest Information Update: 09 Aug 2021
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 09 Aug 2021 New trial record
- 29 Jun 2021 Results presented at the 81st Annual Scientific Sessions of the American Diabetes Association